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Abstract
Background: While the relationship between hemoglobin (Hb) concentrations and pregnancy outcomes has been
studied often, most reports have focused on a specific Hb cutoff used to define anemia. Fewer studies have
evaluated pregnancy outcomes across the entire range of Hb values. Moreover, to date, most studies of the
relationship of Hb concentrations to pregnancy outcomes have been done in high-income countries. Thus, we
have sought to determine the relationship between the range of maternal Hb concentrations and adverse birth
outcomes among South Asian pregnant women.
Methods: For this study, we used data collected from two South Asian countries (Pakistan – Sindh Province and
two sites in India - Belagavi and Nagpur) in a prospective maternal and newborn health registry study. To assess
the association between Hb concentrations and various maternal and fetal outcomes, we classified the Hb
concentrations into seven categories. Regression analyses adjusting for multiple potential confounders were
performed to assess adverse pregnancy outcomes across the range of Hb concentrations.
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Findings: Between January 2012 and December 2018, 130,888 pregnant women were enrolled in the South Asian
sites had a Hb measurement available, delivered and were included in the analyses. Overall, the mean Hb
concentration of pregnant women from the sites was 9.9 g/dL, 10.0 g/dL in the Indian sites and 9.5 g/dL in the
Pakistan site. Hb concentrations < 7 g/dL were observed in 6.9% of the pregnant Pakistani women and 0.2% of the
Indian women. In both the Pakistani and Indian sites, women with higher parity and women with no formal
education had lower Hb concentrations. In the Pakistani site, women > 35 years of age, women with ≥4 children
and those who enrolled in the third trimester were more likely to have Hb concentrations of < 7 g/dL but these
associations were not found for the Indian sites. When adjusting for potential confounders, for both India and
Pakistan, lower Hb concentrations were associated with stillbirth, preterm birth, lower mean birthweight, and
increased risk of low birthweight. In the Pakistani site, there was evidence of a U-shaped relationship between Hb
concentrations and low birth weight, and neonatal mortality, and in India with hypertensive disease.
Interpretation: This study documented the relationship between maternal Hb concentrations and adverse
pregnancy outcomes in women from the Pakistani and Indian sites across the range of Hb values. Both low and
high Hb concentrations were associated with risk of at least some adverse outcomes. Hence, both low and high
values of Hb should be considered risk factors for the mother and fetus.
Keywords: Hemoglobin concetrations, Anemia, South Asia, India, Pakistan, Pregnancy outcome, Stillbirth, Neonatal
mortality, Global network
Background
Anemia remains a significant health problem globally, ac-
counting for more than 60,000 maternal deaths and 3.4%
of global disability-adjusted life years in women aged 15–
49 years [1]. According to the World Health Organization
(WHO), globally, 528.7 million (29.4%) women of repro-
ductive age are anemic with a hemoglobin (Hb) concen-
tration of < 11 g/dL [2]. Of these women, 20.2 million are
defined as severely anemic with a Hb concentration of < 7
g/dL [2]. Rates of anemia are highest in low-resource
countries, especially in central and west Africa where 48%
of reproductive-age women and 56% of all pregnant
women are reported to be anemic and in South Asia,
where 47% of all reproductive-age women and 52% of
pregnant women are reported to be anemic [2].
Multiple adverse maternal and neonatal outcomes have
been attributed to anemia [3]. These outcomes vary ac-
cording to the severity of anemia [4]. Reported maternal
and perinatal outcomes among severely anemic women
include premature rupture of membranes, preterm births
(PTB), hypertensive diseases of pregnancy, puerperal pyr-
exia, fetal distress, small for gestational age, stillbirths,
neonatal and maternal deaths [5]. Findings from system-
atic reviews and meta-analyses have also suggested that in
low-income countries, 25% of low-birth weight (LBW),
44% of PTB, and 21% of perinatal mortality are attribut-
able to anemia [6]. One review observed a relatively higher
anemia-attributable proportion of LBW in Pakistan and
Bangladesh compared to Ghana and India [6]. Similarly,
the highest anemia-attributable proportion of PTB was
observed in Pakistan (54%) followed by India (27%) and
Iran (18%) [6]. Further, studies have also revealed that
women with low Hb concentrations during pregnancy are
at higher risk of antepartum and postpartum hemorrhage,
obstructed labor, and cesarean-section delivery when
compared to the women with normal hemoglobin con-
centrations [7–10].
At the other end of the spectrum, several older studies
have shown that elevated Hb concentrations during
pregnancy are also associated with increased risk of ad-
verse birth outcomes, including PTB, LBW, fetal death
and intrauterine growth retardation [11–14]. However,
the findings have not been consistent [12, 15]. Moreover,
this potential U-shaped relationship, with higher risks of
adverse birth outcomes at both extremes of Hb concen-
trations have been assessed primarily in more developed
countries such as the U.S., Sweden, and Iran [16–18].
Thus, very few studies have described the relationship
between high Hb concentrations and birth outcomes in
low-and middle-income countries (LMIC) and particu-
larly in women from South Asia [11, 12]. Moreover, the
relationship between higher concentrations of Hb with
adverse outcomes, such as antepartum and postpartum
hemorrhage, obstructed labor, and cesarean delivery is
not explored in the literature.
The objective of this study was to assess the associa-
tions across the range of maternal Hb concentrations
and adverse birth outcomes in South Asian pregnant
women as well as evaluating factors related to Hb con-
centrations by country. Differences between the Paki-
stani and Indian sites in the relationship of Hb
concentration and pregnancy outcomes were explored.
An understanding of these outcomes and the association
of Hb concentrations with adverse pregnancy outcomes
is essential to inform policies to improve maternal and
fetal/neonatal outcomes.
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Methods
The Global Network’s Maternal Newborn Health Regis-
try (MNHR) is a multi-site, prospective, ongoing, active
surveillance system to track pregnancies and births in
defined geographic communities (clusters), each with ap-
proximately 300 to 500 deliveries per year. The MNHR
is funded by the Eunice Kennedy Shriver National Insti-
tute of Child Health and Human Development (NICHD)
through grants to the NICHD Global Network for
Women’s and Children’s Health (ClinicalTrials.gov Iden-
tifier: NCT01073475). The aim of the MNHR is to docu-
ment birth outcomes in defined geographical areas and
provide population-based rates of stillbirth, neonatal and
maternal deaths, and other adverse outcomes. The de-
tails of the MNHR are described elsewhere [19].
For this study, we used data collected from the three
South Asian sites (Pakistan – Sindh Province and two
sites in central India - Belagavi and Nagpur). For pur-
pose of analyses, we grouped the two Indian sites, which
had similar demographics, and analyzed the Pakistan site
separately. Since the MNHR began to collect maternal
Hb concentrations in 2012, we included data of women
who were enrolled between January 2012 and December
2018. However, the Pakistani site started routinely
collecting Hb data in 2014. Those pregnant women who
provided consent and had Hb measurements available at
the enrollment visit were included. Women who delivered
before 20weeks, had a medical termination of pregnancy,
were not residents of the study cluster or who had incom-
plete outcome data were excluded from this analysis
(Fig. 1).
Gestational age was based on the best data available,
usually the last menstrual period (LMP), although in the
later years of the study, ultrasound was more widely
used for gestational age determination. PTB was defined
as births < 37 weeks’ gestational age using a project spe-
cific algorithm. The gestational age of the first prenatal
visit was used as a surrogate for the gestational age of
the Hb determination, because Hb was generally mea-
sured at the first prenatal visit and we did not collect the
specific gestational age Hb measurement separately. If
more than one Hb measurement was recorded, only the
first was used in this analysis. The inter-delivery interval
was calculated by subtracting the date of the last delivery
from the date of delivery of the current pregnancy and
converting that time into months.
To assess the association between Hb concentrations
and various maternal outcomes, (maternal mortality,
Fig. 1 Diagram of Maternal Newborn Health study enrollment in India and Pakistan Global Network sites, 2012–2018
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antepartum hemorrhage, postpartum hemorrhage, hyper-
tensive disease of pregnancy/pre-eclampsia/eclampsia,
obstructed labor and cesarean delivery) and fetal/neonatal
outcomes (PTB, LBW, stillbirth and neonatal mortality),
we classified the Hb concentrations into 7 categories, <
7.0 g/dL, 7.0–7.9 g/dL, 8.0–8.9 g/dL, 9.0–9.9 g/dL, 10.0–
10.9 g/dL, 11.0–12.9 g/dL and ≥ 13.0 g/dL. Values of 11.0–
12.9 g/dL are generally considered normal17 and were
used as the reference group for this study to assess the re-
lationship of outcomes with other Hb categories.
Data were entered and edited at each study site prior
to secure transmission to the central data center (RTI
International) where further edits and statistical analyses
were performed. We produced descriptive statistics
stratified by country to examine the different concentra-
tions of Hb for characteristics of pregnant women and
used Cochran-Mantel-Haenszel tests stratified by study
cluster to assess differences in hemoglobin concentra-
tions among these characteristics. Generalized linear
models adjusting for multiple potential maternal con-
founders and using generalized estimating equations to
account for the correlation of outcomes within cluster
were performed to assess the risk of adverse pregnancy
outcomes across the range of Hb concentrations com-
pared to the reference group separately for the Indian
and Pakistani sites. In these models, we also adjusted for
the gestational age at enrollment, as there may be con-
founding associated with gestational age of Hb measure-
ment and outcomes. We then performed locally
weighted scatterplot smoothing (LOESS), a non-
parametric method for fitting a smooth curve to data
points to picture the relationship between maternal Hb
concentrations and four birth outcomes (birth weight,
stillbirth, 7-day neonatal mortality and 28-day neonatal
mortality).
This study was reviewed and approved by all sites’ eth-
ics review committees (Aga Khan University, Karachi,
Pakistan; KLE Academy of Higher Education and Re-
search, Belagavi, India; Lata Medical Research Founda-
tion, Nagpur, India) and the corresponding U.S. partners
(Boston University, Columbia University, Thomas Jeffer-
son University, and RTI International). All women pro-
vided informed consent for participation in the study.
The study was funded by grants from the U.S. National
Institute of Child Health and Human Development.
Results
From the overall cohort in the India and Pakistan sites
from 2012 to 2018, 230,765 women were screened (Fig. 1).
Of these women, 229,218 (99.3%) were eligible and con-
sented to take part in the study. Of these pregnant
women, 227,541 delivered, 68,590 from the Pakistan site
and 158,951 from the two Indian sites. Of these, 49,223
women (6574 Pakistani and 42,649 Indian women) were
excluded, because they were not residents of a study clus-
ter (29,539), had a miscarriage (13,531), or had a medically
terminated pregnancy (6153). Hence, a total of 178,318
deliveries were eligible for further analysis, 62,016 from
the Pakistani site and 116,302 from the two Indian sites.
Of these eligible deliveries, Hb data were available for 130,
888 women, 18,154 from the Pakistani site and 112,734
from the Indian sites. In both countries, about half of the
women were enrolled in the first trimester, about a third
in the second trimester and the remainder in the third tri-
mester or after delivery. Only about 1.5% of the women in
both sites were enrolled after delivery (data not shown).
To assess whether the women for which we had Hb
measurements were similar to those for which Hb mea-
surements were not available, we compared the popula-
tions in Supplemental Table S1. While many of the
differences were significant, the differences between the
two groups were generally small and not likely clinically
important.
Table 1 presents the Hb concentrations by country.
The mean Hb concentration in the Indian sites was 10.0
g/dL (SD 1.0) and 9.5 g/dL (SD 1.7) in the Pakistani site.
6.9% of the pregnant Pakistani women and 0.2% of the
Indian women had Hb concentrations of < 7.0 g/dL.
10.5% of Pakistani women had Hb concentrations from
7.0–7.9 g/dL and 0.9% of Indian women were in this cat-
egory. 18.6% of Pakistani women had Hb concentrations
between 8.0–8.9 g/dL, while 7.1% of the Indian women
had Hb concentrations in this category. Thus, we ob-
served substantial differences in the percent of very low
Hb values between women at the Pakistani and Indian
sites. On the other hand, 20.5% of Pakistani women,
compared to 38.6% of Indian women, had Hb concentra-
tions of 10.0–10.9 g/dL. 16.8% of Pakistani women and
14.3% of Indian women had Hb concentrations of 11.0–
12.9 g/dL. Very few women had Hb concentrations of
Table 1 Hemoglobin concentrations among pregnant women
in Indian and Pakistan Global Network study sites, 2012–2018
Total Pakistan India
Deliveries, N 130,888 18,154 112,734
Hemoglobin g/dL, N (%)
Very low (< 7.0) 1523 (1.2) 1255 (6.9) 268 (0.2)
Low (7.0–7.9) 2903 (2.2) 1911(10.5) 992 (0.9)
Low (8.0–8.9) 11,416 (8.7) 3379 (18.6) 8037 (7.1)
Low (9.0–9.9) 46,946 (35.9) 4486 (24.7) 42,460 (37.7)
Low normal (10.0–10.9) 47,245 (36.1) 3715 (20.5) 43,530 (38.6)
Normal (11.0–12.9) 19,217 (14.7) 3054 (16.8) 16,163 (14.3)
High (≥ 13.0) 1638 (1.3) 354 (1.9) 1284 (1.1)
Hemoglobin mean (SDa) 9.9 (1.1) 9.5 (1.7) 10.0 (1.0)
aSD standard deviation
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≥13.0 g/dL in the Pakistani site (1.9%) and in the Indian
sites (1.1%).
Tables 2 and 3 describe Hb concentrations by the
socio-demographic and clinical characteristics of preg-
nant women for the Pakistani and Indian sites. In both
sites, the percent of women < 20 years of age was low,
4.2% in Pakistan and 6.7% in India. Women with a pri-
mary or higher level of education were much more com-
mon in the Indian site, 90.9% vs 17.1% in the Pakistani
site. The percent of women with parity > 4 was higher in
Pakistan 31.2% vs 1.3% in India. Women enrolled in
both countries tended to have a body mass index (BMI)
< 18.5 kg/m2, 28.7% in Pakistan, and 37.0% in India.
In both the Pakistani and Indian sites, younger women
and primiparous women were more likely to have nor-
mal or higher Hb concentrations, while women of higher
parity were more likely to have lower Hb concentrations.
In the Pakistani site, women > 35 were also more likely
to have lower Hb concentrations. Higher educated
women in both sites tended to have normal Hb concen-
trations, while women with no formal education were
more likely to have low Hb concentrations. In all of the
sites, women with a BMI ≥ 25 kg/m2 tended towards
higher Hb concentrations, however in India only women
BMI < 18.5 kg/m2 tended to have lower Hb concentra-
tions of 8.0–9.9 g/dL. Multiple pregnancy was not statis-
tically associated with Hb concentrations. In the
Pakistani site, inter-delivery interval was not associated
with Hb level. However, in the Indian sites, longer inter-
delivery intervals tended to be associated with a greater
proportion of normal Hb concentrations. Gestational
age at enrollment (and a proxy for the gestational age at
which the Hb measurement was done) was associated
with the Hb concentrations. In the Pakistani site, a
higher proportion of women who enrolled late had lower
Hb concentrations.
Tables 4 and 5 display the unadjusted rates of adverse
maternal and fetal/neonatal outcomes overall and by Hb
category. Maternal and neonatal mortality and stillbirth
as well as the other adverse outcomes including antepar-
tum and postpartum hemorrhage, PTB, and LBW were
observed more often in the Pakistani site than in the In-
dian sites. Hypertensive disease/pre-eclampsia/eclamp-
sia, obstructed labor and cesarean delivery were
observed more often in the Indian sites than in the Paki-
stani site.
To determine the association of the Hb concentrations
and the adverse outcomes, stratified by the Pakistani
(Table 6) and the Indian sites (Table 7), we compared
the risk of the adverse outcomes for each Hb category to
the risk of those outcomes in women with a Hb concen-
tration of 11.0–12.9 g/dL, our reference group. The risks
of outcomes were adjusted for potential confounders in-
cluding maternal age, education level, parity, BMI and
gestational age at enrollment. Because maternal deaths
were relatively rare, the models did not converge to pro-
duce estimates of risk for maternal mortality by Hb con-
centration for either site. For the Pakistani site, women
with Hb concentrations < 7 g/dL had a higher risk of
antepartum hemorrhage compared to women with nor-
mal Hb concentrations; for post-partum hemorrhage,
women with Hb concentrations < 7.9 g/dL showed
higher risk. Hb concentrations were not associated with
hypertensive disease or obstructed labor. Compared to
women with normal Hb concentrations, women with Hb
concentrations < 11 g/dL were less likely to have a
cesarean delivery and had a higher risk for PTB. Stillbirths
were generally more common in the groups with a Hb
concentration < 10 g/dL, with 3 of the 4 < 10 g/dL Hb con-
centration groups having a statistically greater risk of still-
birth than the group with a Hb concentration of 11–12.9
g/dL. Neonatal mortality, whether at < 7 days or < 28 days,
was higher in the groups with Hb concentrations < 7 g/dL
and in the women with a Hb concentration of > 13 g/dL, a
U-shaped relationship. Birthweight was lower in all the
groups with a Hb concentration < 11 g/dL compared to
the reference group. LBW also had a U-shaped relation-
ship with higher risk for Hb concentrations above and
below 11.0 to 12.9 g/dL.
In the Indian sites, as in the Pakistani site, both ante-
partum and postpartum hemorrhage were associated
with very low (< 7.0 g/dL) Hb concentrations. Hyperten-
sive disease was more common in women with very low
and very high Hb concentrations, suggesting a U-shaped
relationship. Furthermore, women with a Hb of 10.0–
10.9 g/dL had lower risk for hypertensive disease com-
pared to 11.0–12.9 g/dL. Risk of obstructed labor and
cesarean delivery was lower in the women with Hb
values between 8 and 11 g/dL and women with Hb
values between 7 and 11 g/dL were also at lower risk for
cesarean delivery. Risk of stillbirth was generally higher
in women with a Hb < 10 g/dL with the results signifi-
cant in 3 of the 4 Hb < 10 g/dL categories. Risk of PTB
was higher for Indian women with Hb < 10 g/dL. Similar
to the Pakistani site, women with a Hb concentration of
< 10 g/dL had a higher risk of neonatal mortality, how-
ever women with a Hg concentration ≥ 13 g/dL did not
show increased risk as in the Pakistani site. In India,
women with Hb concentrations < 9.0 g/dL were at
higher risk to have babies with LBW and women with
Hb concentrations < 11.0 g/dL were more likely to have
babies weighing less than those with normal Hb concen-
trations. The LOESS plots (Fig. 2) illustrate the relation-
ship between Hb concentrations and the outcomes of
birthweight, stillbirth and 7 and 28-day mortality for the
Indian and Pakistani sites. Figure 2 illustrates that there
is a U-shaped relationship between hemoglobin concen-
trations and outcomes such as neonatal mortality and
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Table 2 Socio Demographic and Clinical Characteristics of Pregnant Women by Hemoglobin Concentration for Pakistan
Maternal Characteristics Overall1
N (%)
Maternal Hemoglobin g/dL1, N (%) P-
value2Very low(<
7.0)
Low(7.0–
7.9)
Low(8.0–
8.9)
Low(9.0–
9.9)
Low
normal(10.0–
10.9)
Normal(11.0–
12.9)
High(≥
13.0)
Deliveries, N 18,154 1255 (6.9) 1911
(10.5)
3379
(18.6)
4486
(24.7)
3715 (20.5) 3054 (16.8) 354 (1.9)
Maternal age <.0001
< 20 757 (4.2) 19 (2.5) 79 (10.4) 108 (14.3) 161 (21.3) 171 (22.6) 195 (25.8) 24 (3.2)
20–35 16,240
(89.5)
1115 (6.9) 1669
(10.3)
3004
(18.5)
4003
(24.6)
3356 (20.7) 2774 (17.1) 319 (2.0)
> 35 1157
(6.4)
121 (10.5) 163 (14.1) 267 (23.1) 322 (27.8) 188 (16.2) 85 (7.3) 11 (1.0)
Education <.0001
No formal education 15,042
(82.9)
1160 (7.7) 1716
(11.4)
2941
(19.6)
3775
(25.1)
2972 (19.8) 2214 (14.7) 264 (1.8)
Primary/Secondary 2838
(15.6)
93 (3.3) 184 (6.5) 410 (14.4) 650 (22.9) 670 (23.6) 748 (26.4) 83 (2.9)
University+ 274 (1.5) 2 (0.7) 11 (4.0) 28 (10.2) 61 (22.3) 73 (26.6) 92 (33.6) 7 (2.6)
Parity <.0001
0 3766
(21.0)
135 (3.6) 333 (8.8) 545 (14.5) 813 (21.6) 887 (23.6) 944 (25.1) 109 (2.9)
1–3 8551
(47.8)
569 (6.7) 833 (9.7) 1586
(18.5)
2274
(26.6)
1766 (20.7) 1362 (15.9) 161 (1.9)
≥ 4 5588
(31.2)
531 (9.5) 725 (13.0) 1221
(21.9)
1347
(24.1)
1001 (17.9) 687 (12.3) 76 (1.4)
BMI <.0001
< 18.5 5206
(28.7)
390 (7.5) 577 (11.1) 987 (19.0) 1215
(23.3)
1031 (19.8) 889 (17.1) 117 (2.2)
18.5–25 10,794
(59.5)
769 (7.1) 1185
(11.0)
2085
(19.3)
2735
(25.3)
2161 (20.0) 1685 (15.6) 174 (1.6)
≥ 25 2140
(11.8)
95 (4.4) 147 (6.9) 306 (14.3) 528 (24.7) 523 (24.4) 478 (22.3) 63 (2.9)
Multiple pregnancy 0.3639
Yes 194 (1.1) 13 (6.7) 24 (12.4) 38 (19.6) 44 (22.7) 40 (20.6) 30 (15.5) 5 (2.6)
No 17,906
(98.9)
1231 (6.9) 1881
(10.5)
3335
(18.6)
4433
(24.8)
3668 (20.5) 3014 (16.8) 344 (1.9)
Gestational age at
enrollment
<.0001
1st trimester (< 13,0) 8015
(45.2)
371 (4.6) 675 (8.4) 1286
(16.0)
1817
(22.7)
1758 (21.9) 1875 (23.4) 233 (2.9)
2nd trimester (13,0-23,6) 5547
(31.3)
434 (7.8) 616 (11.1) 1071
(19.3)
1393
(25.1)
1163 (21.0) 786 (14.2) 84 (1.5)
3rd trimester/after
delivery (≥ 24,0)
4166
(23.5)
382 (9.2) 557 (13.4) 938 (22.5) 1178
(28.3)
719 (17.3) 358 (8.6) 34 (0.8)
Inter-delivery interval, N (%) 0.3340
≤ 12months 569 (4.1) 51 (9.0) 70 (12.3) 101 (17.8) 161 (28.3) 93 (16.3) 79 (13.9) 14 (2.5)
12–24months 5263
(37.6)
393 (7.5) 561 (10.7) 1083
(20.6)
1316
(25.0)
1068 (20.3) 765 (14.5) 77 (1.5)
> 24 months 8169
(58.3)
639 (7.8) 913 (11.2) 1606
(19.7)
2116
(25.9)
1570 (19.2) 1181 (14.5) 144 (1.8)
1The overall column displays % of each characteristic, while the hemoglobin columns display % of each hemoglobin category within each maternal
characteristic subgroup
2P-values based on a Cochran-Mantel-Haenszel test for row mean differences based on standard mid-rank (modridit) scores stratified by cluster
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Table 3 Socio Demographic and Clinical Characteristics of Pregnant Women by Hemoglobin Concentration for India
Maternal Characteristics Overall1
N (%)
Maternal Hemoglobin g/dL1, N (%) P-
value2Very low(<
7.0)
Low(7.0–
7.9)
Low(8.0–
8.9)
Low(9.0–
9.9)
Low
normal(10.0–
10.9)
Normal(11.0–
12.9)
High(≥
13.0)
Deliveries, N 112,734 268 (0.2) 992 (0.9) 8037 (7.1) 42,460
(37.7)
43,530 (38.6) 16,163 (14.3) 1284 (1.1)
Maternal age, N (%) <.0001
< 20 7496 (6.7) 31 (0.4) 81 (1.1) 488 (6.5) 2470
(33.0)
2684 (35.8) 1522 (20.3) 220 (2.9)
20–35 104,760
(93.0)
236 (0.2) 908 (0.9) 7504 (7.2) 39,835
(38.0)
40,651 (38.8) 14,565 (13.9) 1061 (1.0)
> 35 446 (0.4) 1 (0.2) 3 (0.7) 41 (9.2) 138 (30.9) 186 (41.7) 74 (16.6) 3 (0.7)
Education, N (%) <.0001
No formal education 10,249
(9.1)
67 (0.7) 143 (1.4) 1005 (9.8) 4165
(40.6)
3582 (34.9) 1184 (11.6) 103 (1.0)
Primary/Secondary 86,809
(77.1)
175 (0.2) 761 (0.9) 6295 (7.3) 33,485
(38.6)
33,306 (38.4) 11,834 (13.6) 953 (1.1)
University+ 15,551
(13.8)
26 (0.2) 84 (0.5) 731 (4.7) 4766
(30.6)
6586 (42.4) 3130 (20.1) 228 (1.5)
Parity, N (%) <.0001
0 49,929
(44.4)
124 (0.2) 397 (0.8) 3090 (6.2) 17,386
(34.8)
19,867 (39.8) 8332 (16.7) 733 (1.5)
1–3 61,118
(54.3)
138 (0.2) 561 (0.9) 4734 (7.7) 24,366
(39.9)
23,133 (37.8) 7647 (12.5) 539 (0.9)
≥ 4 1432 (1.3) 6 (0.4) 31 (2.2) 206 (14.4) 598 (41.8) 424 (29.6) 157 (11.0) 10 (0.7)
BMI, N (%) <.0001
< 18.5 41,555
(37.0)
114 (0.3) 427 (1.0) 3854 (9.3) 17,408
(41.9)
14,622 (35.2) 4746 (11.4) 384 (0.9)
18.5–25 64,980
(57.9)
147 (0.2) 532 (0.8) 3932 (6.1) 23,519
(36.2)
26,312 (40.5) 9809 (15.1) 729 (1.1)
≥ 25 5753 (5.1) 6 (0.1) 26 (0.5) 223 (3.9) 1358
(23.6)
2397 (41.7) 1573 (27.3) 170 (3.0)
Multiple pregnancy, N (%) 0.2983
Yes 991 (0.9) 1 (0.1) 14 (1.4) 77 (7.8) 382 (38.5) 356 (35.9) 152 (15.3) 9 (0.9)
No 111,596
(99.1)
266 (0.2) 978 (0.9) 7943 (7.1) 42,022
(37.7)
43,116 (38.6) 15,998 (14.3) 1273 (1.1)
Gestational age at
enrollment, N (%)
<.0001
1st trimester (< 13,0) 59,855
(53.3)
133 (0.2) 494 (0.8) 4305 (7.2) 22,355
(37.3)
21,711 (36.3) 9771 (16.3) 1086 (1.8)
2nd trimester (13,0-23,6) 38,536
(34.3)
94 (0.2) 366 (0.9) 2794 (7.3) 15,180
(39.4)
15,504 (40.2) 4458 (11.6) 140 (0.4)
3rd trimester/after
delivery (≥ 24,0)
13,953
(12.4)
39 (0.3) 127 (0.9) 914 (6.6) 4795
(34.4)
6168 (44.2) 1863 (13.4) 47 (0.3)
Inter-delivery interval, N (%) <.0001
≤ 12months 903 (2.4) 4 (0.4) 15 (1.7) 76 (8.4) 347 (38.4) 330 (36.5) 122 (13.5) 9 (1.0)
12–24months 10,799
(28.9)
20 (0.2) 109 (1.0) 893 (8.3) 4339
(40.2)
3725 (34.5) 1563 (14.5) 150 (1.4)
> 24 months 25,662
(68.7)
75 (0.3) 252 (1.0) 1857 (7.2) 9461
(36.9)
9747 (38.0) 3938 (15.3) 332 (1.3)
1The overall column displays % of each characteristic, while the hemoglobin columns display % of each hemoglobin category within each maternal
characteristic subgroup
2P-values based on a Cochran-Mantel-Haenszel test for row mean differences based on standard mid-rank (modridit) scores stratified by cluster
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stillbirth for Pakistan. The relationship between
hemoglobin concentrations and birth weight by site
showed that both correlations were positive and signifi-
cantly different from zero, but not high (Pakistan: R2 =
0.073, p < 0.0001 and India: R2 = 0.049, p < 0.0001).
Discussion
This study had several important findings. First, al-
though India and Pakistan originally were part of the
same country and separated only about 70 years ago, the
populations we studied are quite different in a number
of demographic characteristics. The Pakistani population
studied was far less educated and much more likely to
have a higher parity than the Indian population. Both
populations had high numbers of women with a low
BMI although the Pakistani population had twice the
rate of obese women (BMI > 25 kg/m2). Low Hb concen-
trations were common in both populations although the
proportion of women with very low Hb concentrations
was much higher in Pakistan.
The relationships between maternal Hb concentrations and
adverse outcomes were generally similar between the Pakistani
and India sites, although there were differences. Antepartum
and post-partum hemorrhage and stillbirth were associated
with low Hb concentrations in enrolled women in both coun-
tries. Cesarean delivery also occurred less frequently at the
lower Hb concentrations for both sites. Lower Hb concentra-
tions were also associated with lower risk of obstructed labor
in India. Hypertensive disease was not associated with Hb
concentrations in the Pakistani site but was associated with a
U-shaped relationship with Hb concentrations in India. In
both populations, LBW was more common and low mean
birthweight were always more common at the lowest Hb con-
centrations. In the Pakistani site, LBW tended to occur more
often at the highest Hb concentrations as well. Seven and 28-
day neonatal mortality was more common at the lower Hb
concentrations, and in the Pakistani site, there was a U-shaped
relationship with both high and low Hb.
Table 4 Maternal and Fetal/Neonatal Outcomes by Hemoglobin Concentration for Pakistan
Overall Maternal Hemoglobin g/dL
Very low(<
7.0)
Low(7.0–
7.9)
Low(8.0–
8.9)
Low(9.0–
9.9)
Low
normal(10.0–
10.9)
Normal(11.0–
12.9)
High(≥
13.0)
Maternal Outcomes
Deliveries, N 18,154 1255 1911 3379 4486 3715 3054 354
Maternal death < 42 days(Rate/100,000
deliveries)
65 (359) 8 (641) 10 (524) 16 (475) 8 (179) 11 (297) 9 (296) 3 (847)
Antepartum hemorrhage, N (%) 371
(2.0)
44 (3.5) 34 (1.8) 74 (2.2) 80 (1.8) 77 (2.1) 54 (1.8) 8 (2.3)
Postpartum hemorrhage, N (%) 479
(2.6)
47 (3.8) 64 (3.4) 89 (2.6) 116 (2.6) 93 (2.5) 57 (1.9) 13 (3.7)
Hypertensive disease/pre- eclampsia/
eclampsia, N (%)
481
(2.7)
34 (2.7) 44 (2.3) 82 (2.4) 114 (2.5) 95 (2.6) 99 (3.2) 13 (3.7)
Obstructed labor, N (%) 1275
(7.0)
87 (6.9) 124 (6.5) 215 (6.4) 269 (6.0) 274 (7.4) 271 (8.9) 35 (9.9)
C-delivery, N (%) 2713
(15.0)
104 (8.3) 173 (9.1) 390 (11.5) 644 (14.4) 649 (17.5) 670 (22.0) 83 (23.5)
Preterm, N (%) 4670
(25.8)
405 (32.3) 536 (28.2) 883 (26.2) 1161
(25.9)
933 (25.1) 669 (21.9) 83 (23.5)
Fetal/Neonatal Outcomes
Births, N 18,354 1269 1936 3420 4531 3755 3084 359
Stillbirth, N (Rate/1000) 889
(48.5)
105 (82.9) 115 (59.6) 163 (47.7) 208 (45.9) 162 (43.2) 118 (38.3) 18 (50.3)
Neonatal mortality < 7 days, N (Rate/
1000)
709
(40.7)
61 (52.8) 79 (43.6) 131 (40.3) 183 (42.4) 121 (33.8) 113 (38.2) 21 (61.8)
Neonatal mortality < 28 days, N (Rate/
1000)
889
(51.1)
80 (69.2) 101 (55.7) 169 (52.0) 222 (51.5) 157 (43.8) 137 (46.4) 23 (67.6)
Birth weight (g)a, Mean (SD) 2702
(491)
2587 (523) 2672
(491)
2687
(493)
2702
(488)
2727 (476) 2754 (482) 2705
(545)
Low birth weight (< 2500 g)a, N (%) 3950
(22.2)
367 (30.7) 455 (24.6) 772 (23.2) 929 (21.1) 752 (20.6) 586 (19.6) 89 (25.9)
aBirth weight measured within 7 days of delivery
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There are several mechanisms through which low and
high Hb concentrations may be associated with adverse
fetal, neonatal, and maternal outcomes. For example, the
underlying cause of low Hb concentrations is most often
due to iron or vitamin deficiency resulting in impaired
transport of oxygen to the uterus, placenta, and fetus.
This mechanism might explain the increase in preterm
birth, low birth weight and perinatal deaths associated
with low Hb [20]. On the other hand, the association of
high Hb concentrations with adverse outcomes might be
due to other mechanisms. Higher Hb concentrations
may not be a marker for increased red cell production,
but instead may be a result of failure for the plasma vol-
ume to expand. The literature suggests that failure of
the Hb concentrations to fall is associated with up to a
threefold increased risk of pre-eclampsia and the birth
of small for gestational age infants and preterm delivery
[21–24]. Thus, an elevated Hb level is an indicator for
possible pregnancy complications associated with poor
plasma volume expansion, and should not be mistaken
for good iron status [16].
Furthermore, it has been suggested that high Hb concen-
trations may restrict intrauterine growth as a consequence of
high blood viscosity [14]. The increased viscosity related to
low uterine arterial blood flow results in reduced oxygen de-
livery to the fetus. Thus, extremes of Hb concentrations dur-
ing pregnancy appear to be associated with an increase in
adverse outcomes. This issue may be an important consider-
ation for setting standards for appropriate Hb concentrations
during pregnancy. This U-shaped relationship of Hb concen-
trations has been found with adverse outcomes such as still-
birth, preterm birth, and LBW in more developed countries
[11, 16]. Hence, through the present study, we were able to
confirm evidence of a U-shaped relationship between Hb
concentration and several adverse pregnancy outcomes
among South Asian pregnant women.
Strengths and limitations
One of the biggest strengths of our study is the size of
the cohort. To our knowledge, this is the largest cohort
study that looked specifically at the extremes of Hb con-
centrations and its association with maternal and
Table 5 Maternal and Fetal/Neonatal Outcomes by Hemoglobin Concentration for India
Overall Maternal Hemoglobin g/dL
Very low(<
7.0)
Low(7.0–
7.9)
Low(8.0–
8.9)
Low(9.0–
9.9)
Low
normal(10.0–
10.9)
Normal(11.0–
12.9)
High(≥
13.0)
Maternal Outcomes
Deliveries, N 112,734 268 992 8037 42,460 43,530 16,163 1284
Maternal death < 42 days (Rate/100,
000 deliveries)
134
(119)
0 (0) 1 (101) 18 (224) 41 (97) 47 (108) 23 (142) 4 (312)
Antepartum hemorrhage, N (%) 739 (0.7) 6 (2.2) 11 (1.1) 60 (0.7) 301 (0.7) 239 (0.5) 114 (0.7) 8 (0.6)
Postpartum hemorrhage, N (%) 679 (0.6) 10 (3.8) 14 (1.4) 70 (0.9) 209 (0.5) 233 (0.5) 131 (0.8) 12 (1.0)
Hypertensive disease/pre- eclampsia/
eclampsia, N (%)
3685
(3.3)
18 (6.7) 38 (3.8) 255 (3.2) 1287 (3.0) 1314 (3.0) 675 (4.2) 98 (7.6)
Obstructed labor, N (%) 11,546
(10.3)
27 (10.1) 90 (9.1) 749 (9.3) 3970 (9.4) 4557 (10.5) 1982 (12.3) 171 (13.3)
C-delivery, N (%) 28,706
(25.5)
64 (23.9) 203 (20.5) 1766
(22.0)
9664
(22.8)
11,412 (26.2) 5172 (32.0) 425 (33.1)
Preterm, N (%) 12,740
(11.3)
43 (16.2) 141 (14.2) 1050
(13.1)
5060
(12.0)
4629 (10.7) 1676 (10.4) 141 (11.0)
Fetal/Neonatal Outcomes
Births, N 113,749 269 1006 8116 42,853 43,893 16,319 1293
Stillbirth, N (Rate/1000) 2926
(25.7)
15 (55.8) 36 (35.8) 245 (30.2) 1166
(27.2)
1038 (23.7) 392 (24.0) 34 (26.3)
Neonatal mortality < 7 days, N (Rate/
1000)
2097
(18.9)
10 (39.4) 30 (31.0) 182 (23.1) 856 (20.6) 732 (17.1) 266 (16.7) 21 (16.7)
Neonatal mortality < 28 days, N (Rate/
1000)
2593
(23.4)
12 (47.2) 33 (34.1) 228 (29.0) 1038
(24.9)
926 (21.6) 328 (20.6) 28 (22.3)
Birth weight (g)a, Mean (SD) 2707
(462)
2641 (505) 2644
(481)
2670
(472)
2687
(466)
2720 (450) 2744 (469) 2728
(462)
Low birth weight (< 2500 g)a, N (%) 21,575
(19.2)
69 (26.6) 253 (25.7) 1783
(22.3)
8436
(20.0)
7787 (18.0) 2969 (18.5) 278 (21.9)
aBirth weight measured within 7 days of delivery
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neonatal outcomes in South Asian populations in India
and Pakistan. Despite these strengths, our study had
some limitations. First, only 29% of the Pakistani women
had a Hb measured. There were also some differences in
the women with Hb measurements and those without,
and although these differences were small, the results
may not be generalizable to all women in the study.
Also, we did not record the specific gestational age in
pregnancy when the Hb concentrations were measured,
although at all sites the Hb level is taken at the first
antenatal visit. Because Hb concentrations fell slightly as
the pregnancy advanced, we adjusted for the gestational
age of the first visit to reduce confounding. Another
limitation of our study was that our gestational age data
and the rates of PTB were generally based on LMP data
rather than on a gestational age determined by an early
ultrasound. Although there could be bias among those
with Hb data available, we are not aware of any system-
atic differences in Hb collection that may have biased
the relationships we report.
Conclusions
Based on our findings, both low and high values of
Hb should be considered risk factors for the mother
and fetus. Further research is required to understand
the biological processes that underlie our results. In
addition, studies are recommended to identify
whether the Pakistani women have very low Hb con-
centrations due to dietary causes (iron and folic acid
deficiencies), paracytic infections, or whether there
are some underlying hereditary disorders that might
be prevalent among the women such as red cell ab-
normalities or hemoglobinopathies.
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